UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000045242
Receipt number R000051663
Scientific Title Effect of prism adaptation of 3D virtual reality on patients with left unilateral spatial neglect ~ Randomized controlled trial ~
Date of disclosure of the study information 2021/08/30
Last modified on 2024/09/09 17:34:51

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effect of prism adaptation of 3D virtual reality on patients with left unilateral spatial neglect
~ Randomized controlled trial ~

Acronym

Effect of prism adaptation of 3D virtual reality on patients with left unilateral spatial neglect
~ Randomized controlled trial ~

Scientific Title

Effect of prism adaptation of 3D virtual reality on patients with left unilateral spatial neglect
~ Randomized controlled trial ~

Scientific Title:Acronym

Effect of prism adaptation of 3D virtual reality on patients with left unilateral spatial neglect
~ Randomized controlled trial ~

Region

Japan


Condition

Condition

Stroke

Classification by specialty

Rehabilitation medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The purpose of this study is to verify the effect of a single session of prism adaptation using VR on left unilateral spatial neglect by a randomized controlled trial.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Behavioral inattention test Japanese version of normal inspection (BIT-C)

Key secondary outcomes

open loop pointing task


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -but assessor(s) are blinded

Control

Placebo

Stratification

NO

Dynamic allocation

YES

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

Numbered container method


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Maneuver

Interventions/Control_1

Regular rehabilitation and Use a fully immersive VR prism adaptation system.The prism shifts to the right by 20 diopters.
Quickly repeat the reach toward the target displayed in VR.
Reach operation is about 100 times. Single session intervention.

Interventions/Control_2

It uses normal rehabilitation and a prism adaptation system using fully immersive VR, but there is no prism shift. This is a task that appears in VR and quickly repeats the reach movement towards the target.
Reach operation is about 100 times. Single session intervention.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

90 years-old >=

Gender

Male and Female

Key inclusion criteria

(1) Right cerebral hemisphere injury
(2) Hospitalization within 2 to 6 months after the onset of stroke,
(3) 20-90 years old,
(4) No severe cognitive impairment (MMSE> 15 points),
(5) At least one item BIT-C, so less than the cutoff value,
Or, 1 point or more on CBS

Key exclusion criteria

(1) People with lesions under the cerebellar tentorium,
(2) Visually impaired,
(3) Hearing impaired,
(4) People with severe movement disorders or difficulty reaching the right upper limb,
(5) People who cannot understand the task due to aphasia or other cognitive impairment.
(6) Defect in the position of the right finger due to peripheral neuropathy

Target sample size

60


Research contact person

Name of lead principal investigator

1st name Takashi
Middle name
Last name Matsuo

Organization

Kumamoto health Science University

Division name

Faculty of Health Science

Zip code

861-5598

Address

325 Izumi-machi Kita-ku Kumamoto City, Japan

TEL

096-275-2111

Email

matsuo-ta@kumamoto-hsu.ac.jp


Public contact

Name of contact person

1st name Takashi
Middle name
Last name Matsuo

Organization

Kumamoto health Science University

Division name

Faculty of Health Science

Zip code

861-5598

Address

325 Izumi-machi Kita-ku Kumamoto City, Japan

TEL

096-275-2111

Homepage URL


Email

matsuo-ta@kumamoto-hsu.ac.jp


Sponsor or person

Institute

Kumamoto health Science University

Institute

Department

Personal name



Funding Source

Organization

Ministry of Education, Culture, Sports, Science and Technology

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor

Nagasaki University Graduate School of Biomedical Science

Name of secondary funder(s)



IRB Contact (For public release)

Organization

Kumamoto health Science University life science Ethics Review Board

Address

325 Izumi-machi Kita-ku Kumamoto City, Japan

Tel

096-275-2112

Email

kikaku@kumamoto-hsu.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

桜十字福岡病院(福岡県),新武雄病院(佐賀県)


Other administrative information

Date of disclosure of the study information

2021 Year 08 Month 30 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2021 Year 03 Month 01 Day

Date of IRB

2021 Year 06 Month 29 Day

Anticipated trial start date

2021 Year 08 Month 30 Day

Last follow-up date

2024 Year 03 Month 31 Day

Date of closure to data entry

2024 Year 04 Month 20 Day

Date trial data considered complete

2024 Year 05 Month 10 Day

Date analysis concluded



Other

Other related information



Management information

Registered date

2021 Year 08 Month 24 Day

Last modified on

2024 Year 09 Month 09 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000051663